• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰的遗传性肝卟啉病。

Hereditary hepatic porphyrias in Finland.

作者信息

Mustajoki P, Koskelo P

出版信息

Acta Med Scand. 1976;200(3):171-8. doi: 10.1111/j.0954-6820.1976.tb08216.x.

DOI:10.1111/j.0954-6820.1976.tb08216.x
PMID:970225
Abstract

The occurrence of hepatic porphyrias--acute intermittent porphyria (AIP) and variegate porphyria (VP)--in Finland has been studied. During a period of 9 years 107 patients with AIP and 45 patients with VP were found. The prevalence of hereditary hepatic porphyrias was calculated to be 3.4 per 100 000 inhabitants. The patients belonged to 42 different families. Eighty-nine patients (59%) had had acute attacks, whereas 63 were symptomless latent cases. Precipitating factors, symptoms and excretion of porphyrins and their precursors did not significantly differ from what has been reported earlier from other parts of the world. A slight fragility of the skin on the back of the hands was noted in some 50% of VP patients. Abnormal sensitivity to sunlight could not be seen in a single case. However, about 50% of patients with VP showed an abnormal reaction when irradiated with artificial ultraviolet light. The difference in the skin symptoms in South African and Finnish VP patients is discussed.

摘要

对芬兰肝性卟啉病——急性间歇性卟啉病(AIP)和混合型卟啉病(VP)的发病情况进行了研究。在9年的时间里,共发现107例AIP患者和45例VP患者。遗传性肝性卟啉病的患病率经计算为每10万居民中有3.4例。这些患者分属42个不同的家庭。89例患者(59%)曾有过急性发作,而63例为无症状的潜伏病例。诱发因素、症状以及卟啉及其前体的排泄情况与世界其他地区先前报道的情况相比无显著差异。约50%的VP患者手部背部皮肤略显脆弱。未发现有一例对阳光异常敏感。然而,约50%的VP患者在接受人工紫外线照射时会出现异常反应。文中讨论了南非和芬兰VP患者皮肤症状的差异。

相似文献

1
Hereditary hepatic porphyrias in Finland.芬兰的遗传性肝卟啉病。
Acta Med Scand. 1976;200(3):171-8. doi: 10.1111/j.0954-6820.1976.tb08216.x.
2
Variegate porphyria in New England.新英格兰地区的杂色卟啉症。
JAMA. 1982 Jun 11;247(22):3095-102.
3
Variegate porphyria. Twelve years' experience in Finland.
Q J Med. 1980 Spring;49(194):191-203.
4
An Irish family with variegate porphyria.一个患有混合型卟啉病的爱尔兰家庭。
Clin Exp Dermatol. 1984 Nov;9(6):583-90. doi: 10.1111/j.1365-2230.1984.tb00863.x.
5
Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias.通过反相高效液相色谱法测定卟啉病患者尿液和粪便中的卟啉谱。
Clin Chim Acta. 1984 May 16;139(1):55-63. doi: 10.1016/0009-8981(84)90192-x.
6
Porphyrins in renal transplantation.肾移植中的卟啉
Nephron. 1982;30(1):22-7. doi: 10.1159/000182426.
7
Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases.急性卟啉病的预后:急性发作的发生、诱发因素及相关疾病。
Medicine (Baltimore). 1992 Jan;71(1):1-13.
8
Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces.通过测量粪便中异粪卟啉来鉴别迟发性皮肤卟啉症症状型与其他类型的卟啉症。
J Clin Pathol. 1975 Aug;28(8):601-7. doi: 10.1136/jcp.28.8.601.
9
[A family study of the initial Dutch patients with porphyria].[对荷兰最初一批卟啉症患者的家族研究]
Ned Tijdschr Geneeskd. 1989 Dec 23;133(51):2547-52.
10
The incidence of inherited porphyrias in Europe.欧洲遗传性卟啉症的发病率。
J Inherit Metab Dis. 2013 Sep;36(5):849-57. doi: 10.1007/s10545-012-9544-4. Epub 2012 Nov 1.

引用本文的文献

1
Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.了解肝性卟啉症:症状、治疗方法和未满足的需求。
Semin Liver Dis. 2024 May;44(2):209-225. doi: 10.1055/s-0044-1787076. Epub 2024 May 17.
2
Pathogenesis of acute encephalopathy in acute hepatic porphyria.急性肝性卟啉病急性脑病的发病机制。
J Neurol. 2023 May;270(5):2613-2630. doi: 10.1007/s00415-023-11586-5. Epub 2023 Feb 9.
3
Pain in acute hepatic porphyrias: Updates on pathophysiology and management.急性肝卟啉病中的疼痛:病理生理学与管理的最新进展
Front Neurol. 2022 Nov 21;13:1004125. doi: 10.3389/fneur.2022.1004125. eCollection 2022.
4
Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management.卟啉症性神经病:病理生理学、诊断和最新治疗管理。
Curr Neurol Neurosci Rep. 2020 Oct 7;20(12):56. doi: 10.1007/s11910-020-01078-8.
5
Heme biosynthesis and the porphyrias.血红素生物合成与卟啉病。
Mol Genet Metab. 2019 Nov;128(3):164-177. doi: 10.1016/j.ymgme.2019.04.008. Epub 2019 Apr 22.
6
Acute Hepatic Porphyrias in Colombia: An Analysis of 101 Patients.哥伦比亚的急性肝卟啉病:101例患者的分析
JIMD Rep. 2019;44:65-72. doi: 10.1007/8904_2018_125. Epub 2018 Aug 2.
7
Clinical and Laboratory Features of Acute Porphyria: A Study of 36 Subjects in a Chinese Tertiary Referral Center.急性卟啉病的临床和实验室特征:中国一家三级转诊中心36例患者的研究
Biomed Res Int. 2016;2016:3927635. doi: 10.1155/2016/3927635. Epub 2016 Nov 29.
8
Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant Disease.急性间歇性卟啉症:HMBS基因变异的预测致病性表明常染色体显性疾病的外显率极低。
Hum Mutat. 2016 Nov;37(11):1215-1222. doi: 10.1002/humu.23067. Epub 2016 Sep 5.
9
An update of clinical management of acute intermittent porphyria.急性间歇性卟啉症临床管理的最新进展。
Appl Clin Genet. 2015 Sep 1;8:201-14. doi: 10.2147/TACG.S48605. eCollection 2015.
10
Clinically important features of porphyrin and heme metabolism and the porphyrias.卟啉和血红素代谢以及卟啉病的临床重要特征。
Metabolites. 2014 Nov 3;4(4):977-1006. doi: 10.3390/metabo4040977.